Substitute BEMA Product

Substitute BEMA Product. Means any product using BEMA Technology approved by the U.S. Food and Drug Administration or foreign equivalent thereof under a new drug application or abbreviated new drug application and commercialized by BDSI, its Affiliates of sublicensees, following the initial launch, marketing and sale of the Next BEMA Product. For the avoidance of doubt, Substitute BEMA Product, regardless of which jurisdiction first approved, shall include such product in all jurisdictions in which such Substitute BEMA... Product is commercialized. View More